{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:04:26Z","timestamp":1787169866462,"version":"build-2736575974"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder with neuronal degeneration leading to muscular atrophy and respiratory failure. SMA is frequently caused by homozygous deletions that include exon 7 of the survival motor neuron gene SMN1, and its clinical course is influenced by the copy number of a nearby 5q SMN1 paralog, SMN2. Multiple ligation probe amplification (MLPA) and real-time quantitative PCR (qPCR) can detect SMN1 deletions. Yet, qPCR needs normalization or standard curves, and MLPA demands DNA concentrations above those obtainable from dried blood spots (DBSs). We developed a multiplex, droplet digital PCR (ddPCR) method for the simultaneous detection of SMN1 deletions and SMN2 copy number variation in DBS and other tissues. An SMN1 Sanger sequencing process for DBS was also developed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>SMN1, SMN2, and RPP30 concentrations were simultaneously measured with a Bio-Rad AutoDG and QX200 ddPCR system. A total of 1530 DBSs and 12 SMA patients were tested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Population studies confirmed 1 to 5 SMN1 exon 7 copies detected in unaffected specimens, whereas patients with SMA revealed 0 SMN1 copies. Intraassay and interassay imprecisions were &amp;lt;7.1% CV for individuals with \u22651 SMN1 copies. Testing 12 SMA-positive samples resulted in 100% sensitivity and specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>This ddPCR method is sensitive, specific, and applicable to newborn screening and carrier status determination for SMA. It can also be incorporated with a parallel ddPCR T-cell excision circles assay for severe combined immunodeficiencies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1373\/clinchem.2018.293712","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T15:45:24Z","timestamp":1540309524000},"page":"1753-1761","source":"Crossref","is-referenced-by-count":59,"title":["Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy"],"prefix":"10.1093","volume":"64","author":[{"given":"Noemi","family":"Vidal-Folch","sequence":"first","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitar","family":"Gavrilov","sequence":"first","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology"},{"name":"Medical Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiyo","family":"Raymond","sequence":"first","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology"},{"name":"Medical Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Rinaldo","sequence":"first","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology"},{"name":"Medical Genetics"},{"name":"Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Tortorelli","sequence":"first","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology"},{"name":"Medical Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Matern","sequence":"first","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology"},{"name":"Medical Genetics"},{"name":"Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Oglesbee","sequence":"first","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology"},{"name":"Medical Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,1]]},"reference":[{"key":"2020022606060067700_B1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"2020022606060067700_B2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy","volume":"16","author":"Lefebvre","year":"1997","journal-title":"Nat Genet"},{"key":"2020022606060067700_B3","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1086\/302160","article-title":"Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number","volume":"63","author":"Parsons","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2020022606060067700_B4","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","article-title":"A multi-source approach to determine SMA incidence and research ready population","volume":"264","author":"Verhaart","year":"2017","journal-title":"J Neurol"},{"key":"2020022606060067700_B5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy\u2014a literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"2020022606060067700_B6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jmg.2009.066969","article-title":"Differences in SMN1 allele frequencies among ethnic groups within North America","volume":"46","author":"Hendrickson","year":"2009","journal-title":"J Med Genet"},{"key":"2020022606060067700_B7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ana.25101","article-title":"Natural history of infantile-onset spinal muscular atrophy","volume":"82","author":"Kolb","year":"2017","journal-title":"Ann Neurol"},{"key":"2020022606060067700_B8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","article-title":"Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2","volume":"4","author":"Mailman","year":"2002","journal-title":"Genet Med"},{"key":"2020022606060067700_B9","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases","author":"Calucho","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"2020022606060067700_B10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.23995","article-title":"Spinal muscular atrophy: development and implementation of potential treatments","volume":"74","author":"Arnold","year":"2013","journal-title":"Ann Neurol"},{"key":"2020022606060067700_B11","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","article-title":"Disease mechanisms and therapeutic approaches in spinal muscular atrophy","volume":"35","author":"Tisdale","year":"2015","journal-title":"J Neurosci"},{"key":"2020022606060067700_B12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"key":"2020022606060067700_B13","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"2020022606060067700_B14","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"2020022606060067700_B15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JND-180304","article-title":"Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening","volume":"5","author":"Glascock","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"2020022606060067700_B16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1373\/clinchem.2014.231019","article-title":"Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency","volume":"61","author":"Taylor","year":"2015","journal-title":"Clin Chem"},{"key":"2020022606060067700_B17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jpeds.2017.06.042","article-title":"Presymptomatic diagnosis of spinal muscular atrophy through newborn screening","volume":"190","author":"Chien","year":"2017","journal-title":"J Pediatr"},{"key":"2020022606060067700_B18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.gim.0000227970.60450.b2","article-title":"A feasibility study for the newborn screening of spinal muscular atrophy","volume":"8","author":"Pyatt","year":"2006","journal-title":"Genet Med"},{"key":"2020022606060067700_B19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.braindev.2017.04.015","article-title":"Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried blood-spot DNA","volume":"39","author":"Ar Rochmah","year":"2017","journal-title":"Brain Dev"},{"key":"2020022606060067700_B20","first-page":"E78","article-title":"SMA screening system using dried blood spots on filter paper: application of COP-PCR to the SMN1 deletion test","volume":"60","author":"Kato","year":"2015","journal-title":"Kobe J Med Sci"},{"key":"2020022606060067700_B21","first-page":"575","article-title":"A rapid, accurate and simple screening method for spinal muscular atrophy: high-resolution melting analysis using dried blood spots on filter paper","volume":"61","author":"Sa'adah","year":"2015","journal-title":"Clin Lab"},{"key":"2020022606060067700_B22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1373\/clinchem.2012.183038","article-title":"Newborn screening for spinal muscular atrophy by calibrated short-amplicon melt profiling","volume":"58","author":"Dobrowolski","year":"2012","journal-title":"Clin Chem"},{"key":"2020022606060067700_B23","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1373\/clinchem.2007.092312","article-title":"Assessment of liquid microbead arrays for the screening of newborns for spinal muscular atrophy","volume":"53","author":"Pyatt","year":"2007","journal-title":"Clin Chem"},{"key":"2020022606060067700_B24","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1373\/clinchem.2010.144915","article-title":"High-throughput multiplexed T-cell-receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening","volume":"56","author":"Gerstel-Thompson","year":"2010","journal-title":"Clin Chem"},{"key":"2020022606060067700_B25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaci.2009.04.007","article-title":"Development of a routine newborn screening protocol for severe combined immunodeficiency","volume":"124","author":"Baker","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2020022606060067700_B26","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.clinbiochem.2015.03.015","article-title":"Digital PCR analysis of circulating nucleic acids","volume":"48","author":"Hudecova","year":"2015","journal-title":"Clin Biochem"},{"key":"2020022606060067700_B27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jmoldx.2017.05.011","article-title":"A droplet digital PCR method for severe combined immunodeficiency newborn screening","volume":"19","author":"Vidal-Folch","year":"2017","journal-title":"J Mol Diagn"},{"key":"2020022606060067700_B28","first-page":"594","article-title":"[Application of droplet digital PCR technology for genetic testing and prenatal diagnosis of spinal muscular atrophy]","volume":"33","author":"Zou","year":"2016","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"2020022606060067700_B29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1373\/clinchem.2014.230086","article-title":"Screening newborn blood spots for 22q11.2 deletion syndrome using multiplex droplet digital PCR","volume":"61","author":"Pretto","year":"2015","journal-title":"Clin Chem"},{"key":"2020022606060067700_B30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/GIM.0b013e318188d069","article-title":"Carrier screening for spinal muscular atrophy","volume":"10","author":"Prior","year":"2008","journal-title":"Genet Med"},{"key":"2020022606060067700_B31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/AOG.0000000000001948","article-title":"Committee opinion no. 691 summary: carrier screening for genetic conditions","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2020022606060067700_B32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/gim.2013.84","article-title":"An Ashkenazi Jewish SMN1 haplotype specific to duplication alleles improves pan-ethnic carrier screening for spinal muscular atrophy","volume":"16","author":"Luo","year":"2014","journal-title":"Genet Med"},{"key":"2020022606060067700_B33","article-title":"Spinal muscular atrophy: overview of molecular diagnostic approaches","volume":"88","author":"Prior","year":"2016","journal-title":"Curr Protoc Hum Genet"},{"key":"2020022606060067700_B34","article-title":"Evaluation of detection capability for clinical laboratory measurement procedures; approved guideline","volume-title":"CLSI document EP17\u2013A2","author":"Clinical and Laboratory Standards Institute","year":"2012","edition":"2nd Ed"},{"key":"2020022606060067700_B35","article-title":"Evaluation of precision of quantitative measurement procedures; approved guideline","volume-title":"CLSI document EP05\u2013A3","author":"Clinical and Laboratory Standards Institute","year":"2014","edition":"3rd Ed"},{"key":"2020022606060067700_B36","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.nmd.2006.08.011","article-title":"Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy","volume":"16","author":"Arkblad","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"2020022606060067700_B37","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/ac202578x","article-title":"Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification","volume":"84","author":"Pinheiro","year":"2012","journal-title":"Anal Chem"},{"key":"2020022606060067700_B38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4939-7231-9_9","article-title":"Copy number variation analysis by droplet digital PCR","volume":"1654","author":"H\u00e4rm\u00e4l\u00e4","year":"2017","journal-title":"Methods Mol Biol"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/64\/12\/1753\/32643028\/clinchem1753.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/64\/12\/1753\/32643028\/clinchem1753.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T06:15:55Z","timestamp":1582697755000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/64\/12\/1753\/5608629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,1]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2018.293712","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,1]]},"published":{"date-parts":[[2018,12,1]]}}}